Physician profile
Jonathan C Haas
NPI 1104855618
$469.92
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $96.12 · 2021: $138.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $173.20 | 2019-2021 | |
| Surgalign Spine Technologies, INC. | $80.87 | 2019 | |
| Abbott Laboratories | $64.47 | 2020 | |
| Si-Bone, INC. | $36.62 | 2019 | |
| Zimmer Biomet Holdings, INC. | $29.65 | 2019 | |
| Bioventus LLC | $17.69 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.14 | 2021 | |
| Radius Health, INC. | $16.58 | 2021 | |
| Phadia US INC. | $14.07 | 2020 | |
| Horizon Therapeutics Plc | $11.88 | 2021 | |
| Orthofix Medical, INC. | $7.75 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Haas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.